Dequilla, Jesus M.
HRN: 18-20-27 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2023
CEFTAZIDIME 1GM (VIAL)
03/08/2023
03/14/2023
IV
1g
Q8h
CAP HR
Waiting Final Action
03/23/2023
CO-AMOXICLAV 625MG (TAB)
03/23/2023
03/29/2023
PO
625mgtab
Q8
Pneumonia
Waiting Final Action
05/02/2023
CIPROFLOXACIN 500MG (TAB)
05/02/2023
05/11/2023
NGT
500mg
BID
UTI
Waiting Final Action
02/14/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/18/2023
05/25/2023
IV
600mg
OD
Cathether Associated UTI
Checking Final Appropriateness